4th Quarter - Report

PHARMATHENE, INC for PHARMATHENE, INC

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$177,760
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report (this page) Jan 21, 2009 $177,760 Replaced
4th Quarter - Report Jan 20, 2010 $208,877 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Biodefense advanced research and development funding for BARDA/HHS. Economic Stimulus Funding for HHS, BARDA and NIH to support advanced R&D for biodefense vaccines and therapeutics.

LobbyistCovered position, as disclosed
MARK EDWARD COOKE —

Contacted: Homeland Security, Dept of (DHS); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.